Bausch Health Companies Inc. reported $10.9B of revenue over the trailing twelve months, +10% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $10.9B (to Q2 2026). Net income: −$1.09B, trailing twelve months to Q2 2026. Free cash flow: $1.43B, trailing twelve months to Q2 2026. Operating margin: 7.1%, trailing twelve months to Q2 2026.

BHCBausch Health Companies Inc.

Healthcare

$6.04-10% 1Y

$6.04

$4.4452 weeks$7.90

BHC as reported

Bausch Health Companies Inc. reported $10.9B of revenue over the trailing twelve months, +10% on the year before. 10 reported series are charted on this page, each one as filed.

$10.9B

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net income: −$1.09B
Net income · −2377% year on year · trailing twelve months to Q2 2026
Free cash flow: $1.43B
Free cash flow · +28% year on year · trailing twelve months to Q2 2026
Operating margin: 7.1%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for BHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$10.9B	+10%	Q2 2026
Net income	−$1.09B	−2377%	Q2 2026
EPS	−$2.96	−1238%	Q2 2026
Gross margin	71%	n/a	Q2 2018 · 32 quarters behind
Operating margin	7.1%	n/a	Q2 2026
Net margin	−11%	n/a	Q2 2026
ROE	11%	n/a	Q2 2026
ROA	−1.9%	n/a	Q2 2026
ROIC	5.5%	n/a	Q2 2026
Free cash flow	$1.43B	+28%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.